PT - JOURNAL ARTICLE AU - Michael Kidd AU - Alex Richter AU - Angus Best AU - Jeremy Mirza AU - Benita Percival AU - Megan Mayhew AU - Oliver Megram AU - Fiona Ashford AU - Thomas White AU - Emma Moles-Garcia AU - Liam Crawford AU - Andrew Bosworth AU - Tim Plant AU - Alan McNally TI - S-variant SARS-CoV-2 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-QPCR AID - 10.1101/2020.12.24.20248834 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.24.20248834 4099 - http://medrxiv.org/content/early/2020/12/27/2020.12.24.20248834.short 4100 - http://medrxiv.org/content/early/2020/12/27/2020.12.24.20248834.full AB - Birmingham University Turnkey laboratory is part of the Lighthouse network responsible for testing clinical samples under the UK government ‘Test & Trace’ scheme. Samples are analysed for the presence of SARS-CoV-2 in respiratory samples using the Thermofisher TaqPath RT-QPCR test, which is designed to co-amplify sections of three SARS-CoV-2 viral genes.Since more recent information became available regarding the presence of SARS-CoV-2 variants of concern (S-VoC), which can show a suboptimal profile in RT-QPCR tests such as the ThermoFisher TaqPath used at the majority of Lighthouse laboratories, we analysed recently published data for trends and significance of the S-gene ‘dropout’ variant.Results showed that:the population of S-gene dropout samples had significantly lower median Ct values of ORF and N-gene targets compared to samples where S-gene was detectedon a population basis, S-gene dropout samples clustered around very low Ct values for ORF and N targetslinked Ct values for individual samples showed that a low Ct for ORF and N were clearly associated with an S-dropout characteristicwhen conservatively inferring relative viral load from Ct values, approximately 35% of S-dropout samples had high viral loads between 10 and 10,000-fold greater than 1 × 106, compared to 10% of S-positive samples.This analysis suggests that patients whose samples exhibit the S-dropout profile in the TaqPath test are more likely to have high viral loads at the time of sampling. The relevance of this to epidemiological reports of fast spread of the SARS-CoV-2 in regions of the UK is discussed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe testing work in this project is funded by the UK Department of Health and Social CareAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The use of sample result data in this study was reviewed by the Ethics review committee of the College of Medical and Dental Sciences at the University of Birmingham. A waiver was granted allowing samples to be used under ethics gained to aid assay development (NRES Committee West Midlands - South Birmingham 2002/201 Amendment Number 4, 24 April 2013).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in this analysis has been previously published as a supplementary file, and is referenced as such in the manuscript